Long-Acting Injectable Statins—Is It Time for a Paradigm Shift?

Long-Acting Injectable Statins—Is It Time for a Paradigm Shift?

In recent years, advances in pharmaceutical processing technologies have resulted in development of medicines that provide therapeutic pharmacokinetic exposure for a period ranging from weeks to months following a single parenteral administration. Benefits for adherence, dose and patient satisfactio...

Full description

Bibliographic Details
Main Authors: Lee M. Tatham, Neill J. Liptrott, Steve P. Rannard, Andrew Owen
Format: Article
Language:English
Published: MDPI AG 2019-07-01
Series:Molecules
Subjects:
nanoparticles
depot
sustained release
adherence
Online Access:https://www.mdpi.com/1420-3049/24/15/2685

Similar Items

Similar Items